Erythropoietin, tumours and the von Hippel-Lindau gene: Towards identification of mechanisms and dysfunction of oxygen sensing

Nephrology Dialysis Transplantation

Volumn 17, Issue 3, 2002, Pages 356-359

  Wiesener, Michael S ^a   Eckardt, Kai Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Erythropoietin; Gene expression; Hypoxia; Hypoxia inducible transcription factors; Renal tumours; von Hippel Lindau disease

Indexed keywords

ADRENOMEDULLIN; ENDOTHELIN 1; ERYTHROPOIETIN; GLYCOPROTEIN; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; PLATELET DERIVED GROWTH FACTOR; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ARTICLE; BRAIN HEMANGIOMA; CHROMOSOME 3; CONTROLLED STUDY; ERYTHROCYTOSIS; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HEMANGIOBLASTOMA; KIDNEY CARCINOMA; OXYGEN TRANSPORT; PANCREAS CYST; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETINA TUMOR; SPINAL CORD TUMOR; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0036194474     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.3.356     Document Type: Article

References (31)

1. Age-dependent expression of the erythropoietin gene in rat liver and kidneys
2. 2 tension
3. 2 homeostasis by hypoxia-inducible factor 1
4. Oxygen sensing and molecular adaptation to hypoxia
5. Oxygen(es) and the hypoxia-inducible factor-1
6. Regulation of gene expression by oxygen levels in mammalian cells
7. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions
8. 2-dependent degradation domain via the ubiquitin-proteasome pathway
9. Von Hippel-Lindau disease
10. Identification of the von Hippel-Lindau disease tumor suppressor gene
11. Kidney cancer
12. Renal-cell carcinoma
13. Antioncogenes and human cancer
14. Tumour suppression by the human von Hippel-Lindau gene product
15. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
16. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor
17. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
18. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
19. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
20. 2-regulated prolyl hydroxylation
21. 2 sensing
22. Structure of the VHL-elonginC-elonginB complex: Implications for VHL tumor suppressor function
23. Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumorigenesis in von Hippel-Lindau disease
24. Oncogenic alterations of metabolism
25. Activation of the HIF pathway in cancer
26. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases
27. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers and tumor-associated macrophages
28. Expression of hypoxia-inducible factor 1 alpha in brain tumors
29. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas
30. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
31. A conserved family of prolyl-4-hydroxylases that modify HIF